5AM Ventures

5AM Ventures is a life science venture capital firm established in 2002, with offices in California and Massachusetts. The firm specializes in investing in early-stage life science companies, particularly in the biopharmaceutical, drug delivery technologies, and life science instruments sectors.

The company adopts a hands-on approach, often acting as an extension of the operating team for its portfolio companies. It primarily invests in Series A companies and focuses on developing novel therapeutics and life science innovations. 5AM Ventures manages multiple funds, including a $450 million fund dedicated to early-stage investments and a $300 million fund for small and mid-cap biotech and life science companies. Through its 4:59 initiative, the firm collaborates with academics and entrepreneurs to incubate breakthrough science and establish proof-of-concept data for new ventures.